Modulation of the gut microbiota impacts nonalcoholic fatty liver disease: a potential role for bile acids
Year: 2017
Type: article
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, yet the pathogenesis of NAFLD is only partially understood. Here, we investigated the role of the gut bacteria in NAFLD by stimulating the gut bacteria via feeding mice the fermentable dietary fiber, guar gum (GG), and suppressing the gut bacteria via chronic oral administration of antibiotics. GG feeding profoundly altered the gut microbiota composition, in parallel with reduced diet-induced obesity and improved glucose tolerance. Strikingly, despite reducing adipose tissue mass and inflammation, GG enhanced hepatic inflammation and fibrosis, concurrent with markedly elevated plasma and hepatic bile acid levels. Consistent with a role of elevated bile acids in the liver phenotype, treatment of mice with taurocholic acid stimulated hepatic inflammation and fibrosis. In contrast to GG, chronic oral administration of antibiotics effectively suppressed the gut bacteria, decreased portal secondary bile acid levels, and attenuated hepatic inflammation and fibrosis. Neither GG nor antibiotics influenced plasma lipopolysaccharide levels. In conclusion, our data indicate a causal link between changes in gut microbiota and hepatic inflammation and fibrosis in a mouse model of NAFLD, possibly via alterations in bile acids.
Source: Journal of Lipid Research
DOI: 10.1194/jlr.m075713
Authors: Aafke W.F. Janssen, Tom Houben, Saeed Katiraei, Wieneke Dijk, Lily Boutens, Nieke van der Bolt, Zeneng Wang, J. Mark Brown, Stanley L. Hazen, Stéphane Mandard, Ronit Shiri-Sverdlov, Folkert Kuipers, Ko Willems van Dijk, Jacques Vervoort, Rinke Stienstra, Guido J.E.J. Hooiveld, Sander Kersten
Institutions: Wageningen University & Research, Maastricht University, Leiden University Medical Center, Radboud University Nijmegen, Radboud University Medical Center, Cleveland Clinic, Cleveland Clinic Research, Inserm, Université de Bourgogne, Université Bourgogne Franche-Comté, Centre de recherche Translationnelle en Médecine moléculaire, University Medical Center Groningen
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Awards: G237827681, Lipoprotéines et santé : prévention et traitement des maladies inflammatoires non vasculaires et du cancer, G7945804826, Gut Flora metabolism of dietary carnitine and cardiovascular disease, Enzymatic Control of Trimethylamineoxide (TMAO)Induced Atherosclerosis, Alcohol and tissue injury, from mechanisms to treatments
OpenAlex ID: W2618286674
